90 related articles for article (PubMed ID: 8046393)
1. Critical involvement of human T cell leukaemia virus type I virions in mediating the viral mitogenic effect.
Cassé H; Girerd Y; Gazzolo L; Duc Dodon M
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1909-16. PubMed ID: 8046393
[TBL] [Abstract][Full Text] [Related]
2. IgM secreted by human T lymphoma virus-I-infected and transformed human B cell clones recognize a 66-kilodalton host-encoded protein.
Ng VL; Rainer C; Oliver MR; Marsh J; Wood P; Reyes GR; McGrath MS
J Immunol; 1989 Oct; 143(8):2501-7. PubMed ID: 2477445
[TBL] [Abstract][Full Text] [Related]
3. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
[TBL] [Abstract][Full Text] [Related]
4. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.
Kimata JT; Palker TJ; Ratner L
J Virol; 1993 Jun; 67(6):3134-41. PubMed ID: 7684460
[TBL] [Abstract][Full Text] [Related]
5. Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system.
Arp J; Ford CM; Palker TJ; King EE; Dekaban GA
J Gen Virol; 1993 Feb; 74 ( Pt 2)():211-22. PubMed ID: 8429302
[TBL] [Abstract][Full Text] [Related]
6. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I.
Gazzolo L; Duc Dodon M
Nature; 1987 Apr 16-22; 326(6114):714-7. PubMed ID: 3031513
[TBL] [Abstract][Full Text] [Related]
7. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
[TBL] [Abstract][Full Text] [Related]
8. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Jacobson S; Reuben JS; Streilein RD; Palker TJ
J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
[TBL] [Abstract][Full Text] [Related]
9. A truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions.
Carrington CV; Weiss RA; Schulz TF
Virology; 1994 Jul; 202(1):61-9. PubMed ID: 8009867
[TBL] [Abstract][Full Text] [Related]
10. A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells.
Paré ME; Gauthier S; Landry S; Sun J; Legault E; Leclerc D; Tanaka Y; Marriott SJ; Tremblay MJ; Barbeau B
Virology; 2005 Aug; 338(2):309-22. PubMed ID: 15963547
[TBL] [Abstract][Full Text] [Related]
11. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
[TBL] [Abstract][Full Text] [Related]
12. Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.
Mirsaliotis A; Nurkiyanova K; Lamb D; Woof JM; Brighty DW
J Virol; 2007 Jun; 81(11):6019-31. PubMed ID: 17376912
[TBL] [Abstract][Full Text] [Related]
13. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
15. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
Moriuchi H; Moriuchi M
Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
[TBL] [Abstract][Full Text] [Related]
16. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
17. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
18. Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Maeda Y; Terasawa H; Tanaka Y; Mitsuura C; Nakashima K; Yusa K; Harada S
J Virol; 2015 Jan; 89(1):502-11. PubMed ID: 25339765
[TBL] [Abstract][Full Text] [Related]
19. Infection and cellular activation by human T-cell leukemia viruses, types I and II.
Martin TC; Southern PJ
Virology; 1996 Jul; 221(2):375-81. PubMed ID: 8661450
[TBL] [Abstract][Full Text] [Related]
20. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
Lipka K; Tebbe B; Finckh U; Rolfs A
Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
